- Visibility 188 Views
- Downloads 55 Downloads
- Permissions
- DOI 10.18231/j.ijced.2024.070
-
CrossMark
- Citation
Quality of life in alopecia areata: A disease specific questionnaire
- Author Details:
-
Teja Sree *
-
Pravallika Penumatsa
-
Laxmi Shalini Chilakapati
-
Haritha Samanthula
Abstract
Background: Alopecia areata (AA) is an autoimmune disease, impacts 2% of the population worldwide and has a significant impact on the quality of life (QOL) of individuals.
Aims: To assess quality of life in patients with alopecia areata using Dermatology Life Quality Index (DLQI). To study the quality of life in relation to age group and gender.
Materials and Methods: In this study 40 patients with alopecia areata were enrolled and asked to complete the DLQI questionnaire.
Results: Out of the 40 patients with AA, there were 26 (65%) males and 14 (35%) females with a male to female ratio of 1.85: 1. A majority (58.03%) of patients were between 31 and 40 years of age. Employees and students were more affected. Patients with longer duration had moderate to very large effect on QOL. 65% patients were concerned about their disease.
Conclusion: This study indicates that alopecia areata has a small to very large effect on the quality of life of the patients. Hence, Psychological evaluation and support should be considered.
Introduction
Alopecia areata (AA) is chronic, immune-mediated, relapsing, nonscarring disorder that causes hair loss and affects people of all races and genders, occurring in about 2% of the population.[1], [2], [3], [4] Both genetic predisposition [5], [6], [7], [8], [9] and environmental factors[10], [11] contribute to its onset.
AA is classically characterized by a rapid onset, during which individuals experience hair loss in well-circumscribed patches. This condition mostly affects the scalp or beard area; however, complete loss of hair on the scalp could be observed in severe cases.[12] Body hair involvement and nail changes might also be present in some patients. [13]
Despite being benign, AA can cause significant psychological distress in patients and their family members. [14] Previous studies have shown that this condition could increase the prevalence of mood disorders, including anxiety and depression, [15] and other studies have demonstrated a tight correlation between AA and psychiatric disorders.
It has been well documented that anxiety and depression induced by this chronic disorder could negatively affect the disease's course via stress mediators. [16] Although quality of life (QoL) assessment was almost unknown in dermatology until about 20 years ago, it has become increasingly important due to the visibility of dermatological diseases affecting patients' appearance and impairing emotional status and social interactions. [17]
In this study, we assessed the quality of life in patients with alopecia areata using the Dermatology Life Quality Index (DLQI).
Aim of the Study
To assess quality of life in patients with alopecia areata using Dermatology Life Quality Index (DLQI). To study the quality of life in relation to age group and gender.
Materials and Methods
All patients diagnosed with alopecia areata who attended the Dermatology Outpatient Department (OPD) between February 2024 and May 2024 were included in this study. The study protocol was approved by the institutional ethics committee. Patients who met the inclusion and exclusion criteria were enrolled after providing informed consent. The diagnosis of alopecia areata was established based on clinical evaluation.
Inclusion criteria
All the patients with clinical signs of Alopecia Areata who are between 20 and 70 years old visit the Dermatology OPD.
Exclusion criteria
Patients who have visible cutaneous deformities
Patients with mental retardation or psychiatric disorders which prevent the right judgment of the person.
Those not consenting participate in the study.
The clinical details including age, sex, occupation, age of onset, duration of the disease, family history of AA, site of onset, sites affected, precipitating / aggravating factors, associated diseases with special reference to atopic disorders, thyroid disease, or any other significant disease were recorded for all the patients .
The Dermatology Life Quality Index questionnaire given by Finlay et al.,[18] was used, which had a total of 10 questions related to symptoms, feelings, friendships, sports activities, family activities, clothing pattern, work, studies, sexual activities, and treatment.
Dermatology life quality index (dlqi) questionnaire
How itchy, sore, painful or stinging has your lesion been?
How embarrassed or self-conscious have you been?
How much has the lesion interfered with you going shopping or looking after your home or garden
How much the lesion influenced the clothes you wear?
How much has the lesion affected any social or leisure activities?
How much has the lesion made It difficult for you to do any sport?
Has the lesion prevented you from working or studying?
How much has the lesion created problems with your partner or any of your close friends or relatives?
How much has the lesion caused any sexual difficulties?
How much of a problem has the treatment for your skin been, for example by making your home messy, or by taking up time?
Each question was answered by ′not at all′, ′only a little′, ′quite a lot′ or ′very much′. The maximum score for each of the 10 questions was 3, making a maximum possible score of 30. The validated DLQI score bandings used were:
Score |
Interpretation |
0 – 1 |
No effect at all |
2 – 5 |
Small effect |
6 – 10 |
Moderate effect |
11 – 20 |
Very large effect |
21 – 30 |
Extremely large effect |
Statistical methodology
Data was entered in MS excel and descriptive statistics done. Percentages, line diagrams, pie charts were used for the analyzation of the data.
Results
Out of the 40 patients with AA, there were 26 (65%) males and 14 (35%) females with a male to female ratio of 1.85: 1. A majority (58.03%) of patients were between 31 and 40 years of age. The duration of the disease was found to be extremely variable. It varied from two weeks to several years. 65% patients were concerned about their disease.
Sex |
Female |
Male |
Total |
Age (years) |
|
|
|
20-29 |
4 |
11 |
15 |
30-39 |
7 |
6 |
13 |
40-49 |
2 |
6 |
8 |
>50 |
1 |
3 |
4 |
Effect |
Females |
% |
Males |
% |
Total |
% |
No effect |
4 |
30.76 |
10 |
37.03 |
14 |
35 |
Small effect |
4 |
30.76 |
4 |
14.81 |
8 |
20 |
Moderate effect |
3 |
23.07 |
11 |
40.74 |
14 |
35 |
Very large effect |
2 |
15.38 |
2 |
7.4 |
4 |
10 |
Extremely large effect |
0 |
|
0 |
|
0 |
|
Occupation |
Total |
% |
Home maker |
08 |
20% |
Student |
10 |
25% |
Farmer |
02 |
5% |
Employee |
20 |
50% |
Occupation |
Total |
Effect of the disease |
|||
No effect |
Small effect |
Moderate effect |
Very large effect |
||
Home maker |
08 |
2 (25%) |
3(37.5%) |
3(37.5%) |
0 |
Student |
10 |
3(30%) |
1(10%) |
4(40%) |
2(20%) |
Farmer |
02 |
0 |
0 |
2(100%) |
0 |
Employee |
20 |
9(45%) |
4(20%) |
5(25%) |
2(10%) |
Duration (weeks) |
Frequency (n= 40) |
Percentage (%) |
1-6 |
18 |
45% |
7-12 |
14 |
35% |
13-18 |
5 |
12.5% |
19-24 |
3 |
7.5% |
Duration (weeks) |
Total (n=40) |
Effect of the disease |
|||
No effect |
Small effect |
Moderate effect |
Very large effect |
||
1-6 |
18 |
12(66.6%) |
2(11.11%) |
4(22.22%) |
0 |
7-12 |
14 |
2(14.2%) |
5(35.7%) |
6(42.8%) |
1(7.14%) |
13-18 |
5 |
0 |
1(20%) |
3(60%) |
1(20%) |
19-24 |
3 |
0 |
0 |
1(33.33%) |
2(66.66%) |
Discussion
AA is a recurring, chronic illness that significantly lowers a patient's quality of life by affecting their ability to build human relationships. [19]
Numerous QOL tools have been validated to assess the influence of skin disorders on quality of life. [20]
A well-validated measure unique to dermatology is the Dermatology Life Quality Index (DLQI), which is utilized in numerous disorders. [21]
Alzolibani et al. (2012) study showed men appear to be more seriously impacted by AA than women. [22] Similarly in this study, males were more affected than females.
In this study, 50% of the patients were employees, 25% were students, 20% were home makers, 5% were farmers. The majority (75%) were employees and students.
In Abedini R et al. study,[23] it was noted that severe group had higher amount of unemployment.
In this study, Employees and students were more affected, likely due to their increased social interactions compared to homemakers and farmers. Therefore, more than 50% of the patients belonged to this group.
Patients with alopecia areata presented with durations ranging from 1 week to 6 months: 45% of patients had a duration between 1-6 weeks, 35% between 7-12 weeks, 12.5% between 13-18 weeks, and 7.5% between 19-24 weeks.
In Al-Mutairi and Eldin [24] found that the duration of illness did not significantly impact total DLQI scores.
Patients with longer duration had moderate to very large effect on QOL, whereas those with shorter durations (66.6%) reported no effect, with 22.22% experiencing a moderate effect.
Several studies have suggested a small but significant influence of psychological factors in the development and progression of AA. [15], [25], [26]
Tan E et al. (2002) demonstrated in their study that AA partly negatively impacts health-related quality of life. [27]
According to Al-Mutairi N, et al,[24] patients with severe types of AA not only experience profound negative psychological effects but also significant disruptions in social life, leading to avoidance of social gatherings, changes in hairstyle, and alterations in clothing.
In this study, 35% were completely unaffected by the lesion, and experiencing no impact on their ability to work, study, shop, play sports, or engage in other social activities. Neither did the lesion cause issues with any of their close friends or family members.
20% experienced a small effect in terms of embarrassment and affected social activities.
35% showed a moderate effect due to itchy lesions, embarrassment, and social activity.
10% showed a very large effect due to itchy lesions, sexual difficulties, disturbance in work life, and social activity.
The lesion had no effect on sexual activity in 90% of cases.
Conclusion
This study indicates that alopecia areata has small to very large effect on the quality of life of the patients. Hence, Psychological evaluation and support should be considered.
Source of Funding
None.
Conflicts of Interest
There are no conflicts of interest.
References
- Alexis A, Dudda-Subramanya R, Sinha A. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol. 2004;14(6):364-70. [Google Scholar]
- Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc. 2004;9(1):73-8. [Google Scholar]
- Gilhar A, Kalish R. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev. 2006;5(1):64-9. [Google Scholar]
- Cooper G, Bynum M, Somers E. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3-4):197-207. [Google Scholar]
- Martinez-Mir A, Zlotogorski A, Christiano A. Search for susceptibility genes in alopecia areata. J Investig Dermatol Symp Proc. 2005;10(3):281-2. [Google Scholar]
- Martinez-Mir A, Zlotogorski A, Gordon D. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet. 2007;80:316-28. [Google Scholar]
- Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007;117(8):2019-27. [Google Scholar]
- Megiorni F, Pizzuti A, Mora B, Rizzuti A, Garelli V, Maxia C. Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with Alopecia areata in the Italian population. Br J Dermatol. 2011;165(4):823-7. [Google Scholar]
- Petukhova L, Cabral RM, Mackay-Wiggan J, Clynes R, Christiano AM. The genetics of alopecia areata: what’s new and how will it help our patients?. Dermatol Ther. 2011;24(3):326-36. [Google Scholar]
- Díaz-Atienza F, Gurpegui M. Environmental stress but not subjective distress in children or adolescents with alopecia areata. J Psychosom Res. 2011;71(2):102-7. [Google Scholar]
- Rodriguez T, Fernandes K, Dresser K, Duvic M. National Alopecia Areata Registry. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol. 2010;62(3):525-7. [Google Scholar]
- Mcdonagh A, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol. 2002;27(5):405-9. [Google Scholar]
- Pratt C, King L, AM, Christiano A, Sundberg J. Alopecia areata. Nat Rev Dis Primers. 2017;3. [Google Scholar] [Crossref]
- Basra M, Edmunds O, Salek M, Finlay A. Measurement of family impact of skin disease: Further validation of the Family Dermatology Life Quality Index (FDLQI). J Eur Acad Dermatol Venereol. 2008;22(7):813-21. [Google Scholar]
- Güleç A, Tanriverdi N, Dürü C, Saray Y, Akçali C. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol. 2004;43(5):352-6. [Google Scholar]
- Matzer F, Egger J, Kopera D. Psychosocial stress and coping in alopecia areata: A questionnaire survey and qualitative study among 45 patients. Acta Derm Venereol. 2011;91(3):318-27. [Google Scholar]
- Ayala F, Nino M, Fabbrocini G, Panariello L, Balato N, Foti C. Quality of life and contact dermatitis: a disease-specific questionnaire. Dermatitis. 2010;21(2):84-90. [Google Scholar]
- Finlay A, Khan G. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-6. [Google Scholar]
- Fabbrocini G, Panariello L, Vita VD, Vincenzi C, Lauro C, Nappo D. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol. 2013;27(3):276-81. [Google Scholar]
- Halioua B, Beumont M, Lunel F. Quality of life in dermatology. Int J Dermatol. 2000;39(11):801-6. [Google Scholar]
- Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9:169-80. [Google Scholar]
- Alzolibani AA. Epidemiologic and genetic characteristics of alopecia areata (part 1). Acta Dermatovenerol Alp Pannonica Adriat. 2011;20(4):191-8. [Google Scholar]
- Abedini R, Hallaji Z, Lajevardi V, Nasimi M, Khaledi M, Tohidinikc H. Quality of life in mild and severe alopecia areata patients. Int J Womens Dermatol. 2017;4(2):91-4. [Google Scholar]
- Al-Mutairi N, Eldin O. Clinical profile and impact on quality of life: Seven years experience with patients of alopecia areata. Indian J Dermatol Venereol Leprol. 2011;77(4):489-93. [Google Scholar]
- Brajac I, Tkalcic M, Dragojevic´ D, Gruber F. Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata. J Dermatol. 2003;30(12):871-8. [Google Scholar]
- Manolache L, Petrescu-Seceleanu D, Benea V. Alopecia areata and relationship with stressful events in children. J Eur Acad Dermatol Venereol. 2009;23(1):107-9. [Google Scholar]
- Tan E, Tay YK, Goh CL, Giam YC. The pattern and profile of alopecia areata in Singapore-a study of 219 Asians. Int J Dermatol. 2002;41(11):748-53. [Google Scholar]
How to Cite This Article
Vancouver
Sree T, Penumatsa P, Chilakapati LS, Samanthula H. Quality of life in alopecia areata: A disease specific questionnaire [Internet]. IP Indian J Clin Exp Dermatol. 2024 [cited 2025 Oct 08];10(4):398-401. Available from: https://doi.org/10.18231/j.ijced.2024.070
APA
Sree, T., Penumatsa, P., Chilakapati, L. S., Samanthula, H. (2024). Quality of life in alopecia areata: A disease specific questionnaire. IP Indian J Clin Exp Dermatol, 10(4), 398-401. https://doi.org/10.18231/j.ijced.2024.070
MLA
Sree, Teja, Penumatsa, Pravallika, Chilakapati, Laxmi Shalini, Samanthula, Haritha. "Quality of life in alopecia areata: A disease specific questionnaire." IP Indian J Clin Exp Dermatol, vol. 10, no. 4, 2024, pp. 398-401. https://doi.org/10.18231/j.ijced.2024.070
Chicago
Sree, T., Penumatsa, P., Chilakapati, L. S., Samanthula, H.. "Quality of life in alopecia areata: A disease specific questionnaire." IP Indian J Clin Exp Dermatol 10, no. 4 (2024): 398-401. https://doi.org/10.18231/j.ijced.2024.070